Pharmacy

Riomont Acomplia

Home » Prescription Drugs 14 » Riomont Acomplia

Appetite suppressant Anti obesity drug. significantly reducing human visceral fat (the metabolically active fat wrapped around the bodys vital organs in the abdomen Liver. A single pill has been found to stop both food and cigarette cravings enough to help people quit smoking and lose weight and could also help curb other unhealthy urges. In one study the medicine helped people who were overweight drop an average of 20 pounds and in another doubled the chances that smokers would quit. Acomplia contains the active ingredient Rimonabant. It is a selective CB1 Endocannabinoid Receptor Antagonist.Rimonabant works by blocking receptors of a substance called cannabinoid 1 which stimulates hunger and other cravings in the brain and is also present in fat tissue. Active Ingredient: Rimonabant

Buy Riomont Acomplia and other Prescription Drugs 14 products online at Medstore.

Buy Online at Medstore - Click Here!

About Riomont Acomplia:

Product Type: Prescription Drugs 14

Riomont ( Acomplia Generic Rimonabant )

Riomont (Acomplia Generic Rimonabant)

Acomplia Generic Rimonabant

20mg Acomplia Generic Rimonabant Riomont

View more Prescription Drugs 14

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.